IL6R and metabolic dysfunction-associated steatohepatitis: Interestingly, also elevated hepatic and circulating levels of IL-1 receptor antagonist (IL-1RA) are observed in NASH patients, and were even found to be correlated to the degree of lobular inflammation (77).